2018
DOI: 10.1136/medethics-2017-104610
|View full text |Cite
|
Sign up to set email alerts
|

Towards theoretically robust evidence on health equity: a systematic approach to contextualising equity-relevant randomised controlled trials

Abstract: Reducing inequalities in health and the determinants of health is a widely acknowledged health policy goal, and methods for measuring inequalities and inequities in health are well developed. Yet, the evidence base is weak for how to achieve these goals. There is a lack of high-quality randomised controlled trials (RCTs) reporting impact on the distribution of health and non-health benefits and lack of methodological rigour in how to design, power, measure, analyse and interpret distributional impact in RCTs. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…In some cases, the biomedical "gold standard" designs (e.g., the randomized controlled trial) can be used, including cluster-randomized trials [41] and stepped-wedge designs [42]. There is growing literature on how to conduct randomized trials that are equity-relevant [43][44][45]. In other cases, particularly when the independent variable (e.g., a policy) cannot be randomized, non-randomized designs and methods are appropriate (e.g., time-series designs, quasi-experiments, natural experiments, difference in difference studies) [41,46].…”
Section: Underdeveloped Measures and Methodsmentioning
confidence: 99%
“…In some cases, the biomedical "gold standard" designs (e.g., the randomized controlled trial) can be used, including cluster-randomized trials [41] and stepped-wedge designs [42]. There is growing literature on how to conduct randomized trials that are equity-relevant [43][44][45]. In other cases, particularly when the independent variable (e.g., a policy) cannot be randomized, non-randomized designs and methods are appropriate (e.g., time-series designs, quasi-experiments, natural experiments, difference in difference studies) [41,46].…”
Section: Underdeveloped Measures and Methodsmentioning
confidence: 99%
“…As an analytical framework, translational ethics provides a broad and useful frame within which to structure the required reflexivity to support an ethics for researchers who are pursuing impact. Importantly, this analytical framework is context-sensitive and puts the burden of providing justification on the researchers, but it does not provide any resources with which to identify substantial limitations to appropriate impact [ 18 ]. According to our working hypothesis, such assessments require support from substantive ethical and political discourses that address the issue of distribution of power at the intersection of producing and applying knowledge.…”
Section: Main Textmentioning
confidence: 99%
“…Unjust health inequality is influenced by inequality in the socioeconomical, cultural and environmental factors (eg, access to clean water) that shape people’s living conditions 13. Although theories diverge as to what makes the resulting health disparities unfair, there is broad consensus that health inequality associated with socioeconomic determinants of health creates inequity and calls for amendment 14. For this reason, ML fairness should not only be about avoiding prejudices and favouritism, but also about reducing unfair health inequalities,15 particularly those associated with socioeconomic health determinants .…”
Section: Introductionmentioning
confidence: 99%
“…13 Although theories diverge as to what makes the resulting health disparities unfair, there is broad consensus that health inequality associated with socioeconomic determinants of health creates inequity and calls for amendment. 14 For this reason, ML fairness should not only be about avoiding prejudices and favouritism, but also about reducing unfair health inequalities, 15 particularly those associated with socioeconomic health determinants. In line with Rajkomar and colleagues’ reasoning, 15 to avoid ML in healthcare contributing to maintaining or reinforcing health inequities, fairness should be operationalised into ML processes by ensuring equal outcome across socioeconomic status, equal performance of models across socioeconomic groups, as well as equal allocation of resources.…”
Section: Introductionmentioning
confidence: 99%